These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20102313

  • 1. Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease.
    Worthmann K, Peters I, Kümpers P, Saleem M, Becker JU, Agustian PA, Achenbach J, Haller H, Schiffer M.
    Growth Factors; 2010 Apr; 28(2):129-38. PubMed ID: 20102313
    [Abstract] [Full Text] [Related]

  • 2. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
    Peters I, Tossidou I, Achenbach J, Woroniecki R, Mengel M, Park JK, Paschy M, de Groot K, Haller H, Schiffer M.
    J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
    [Abstract] [Full Text] [Related]

  • 3. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 Jun; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 4. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.
    Achenbach J, Mengel M, Tossidou I, Peters I, Park JK, Haubitz M, Ehrich JH, Haller H, Schiffer M.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3138-45. PubMed ID: 18458033
    [Abstract] [Full Text] [Related]

  • 5. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
    Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, Bonet J, Romero R.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3914-23. PubMed ID: 21414970
    [Abstract] [Full Text] [Related]

  • 6. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
    Nezhad ST, Momeni B, Basiratnia M.
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
    [Abstract] [Full Text] [Related]

  • 7. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
    Ren Fail; 2008 Sep; 30(5):477-83. PubMed ID: 18569926
    [Abstract] [Full Text] [Related]

  • 8. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 1996 Sep; 47(4):209-14. PubMed ID: 9097714
    [Abstract] [Full Text] [Related]

  • 9. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS.
    Mueller-Deile J, Kümpers P, Achenbach J, Park JK, Mengel M, Haller H, Schiffer M.
    J Nephrol; 2012 Sep; 25(5):802-9. PubMed ID: 22241637
    [Abstract] [Full Text] [Related]

  • 10. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
    Li YH, Huang HC, Liu G, Zhang YK.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):135-8. PubMed ID: 15100729
    [Abstract] [Full Text] [Related]

  • 11. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
    Am J Nephrol; 2008 Apr; 28(1):83-90. PubMed ID: 17914249
    [Abstract] [Full Text] [Related]

  • 12. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS, Sergeeva TV.
    Ter Arkh; 2002 Apr; 74(6):31-3. PubMed ID: 12136479
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical detection of galectin-1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies.
    Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwińska A, Witt M.
    Histopathology; 2007 Oct; 51(4):468-76. PubMed ID: 17880528
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y.
    Nephron Clin Pract; 2012 Oct; 120(1):c1-7. PubMed ID: 22126861
    [Abstract] [Full Text] [Related]

  • 15. The application of electron microscopic morphometry as a helpful method in the diagnosis of focal segmental glomerulosclerosis (FSGS) early phase. II. Clinical usefulness of electron microscopic morphometric studies in cases of minimal change disease (MCD) and mesangioproliferative glomerulonephritis (GNMES) with suspicion of progression into focal segmental glomerulosclerosis (FSGS).
    Woźniak A, Bortkiewicz E, Salwa-Zurawska W, Kaczmarek E, Maciejewski J.
    Pol J Pathol; 2001 Oct; 52(1-2):37-46. PubMed ID: 11505679
    [Abstract] [Full Text] [Related]

  • 16. Expression of sialidase and dystroglycan in human glomerular diseases.
    Vogtländer NP, van der Vlag J, Bakker MA, Dijkman HB, Wevers RA, Campbell KP, Wetzels JF, Berden JH.
    Nephrol Dial Transplant; 2010 Feb; 25(2):478-84. PubMed ID: 19755471
    [Abstract] [Full Text] [Related]

  • 17. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
    Doublier S, Musante L, Lupia E, Candiano G, Spatola T, Caridi G, Zennaro C, Carraro M, Ghiggeri GM, Camussi G.
    Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
    [Abstract] [Full Text] [Related]

  • 18. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
    Kuo HT, Kuo MC, Chiu YW, Chang JM, Guh JY, Chen HC.
    Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
    [Abstract] [Full Text] [Related]

  • 19. Is vacuolization of podocytes and glomerular endothelial cells of prognostic value with respect to FSGS?
    Salwa-Zurawska W, Woźniak A, Biczysko W, Bortkiewicz E, Kaczmarek E, Maciejewski J.
    Pol J Pathol; 1998 Apr; 49(3):165-74. PubMed ID: 9810176
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome.
    Kavoura E, Gakiopoulou H, Paraskevakou H, Marinaki S, Agrogiannis G, Stofas A, Boletis I, Patsouris E, Lazaris AC.
    Hum Pathol; 2011 Feb; 42(2):227-35. PubMed ID: 21106221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.